The hepatitis C virus (HCV) has been shown to cause progressive and chronic liver damage.1 Interferon therapy apparently eradicates HCV in 20 to 30 percent of patients, but the follow-up in published studies is generally short (6 to 18 months) and never exceeds 3 to 5 years. Our findings indicate that at the doses used, interferon has little, if any, long-term efficacy in patients with chronic hepatitis C.

Lack of sustained efficacy of interferon in patients with chronic hepatitis C

CONCIA, Ercole;
1996

Abstract

The hepatitis C virus (HCV) has been shown to cause progressive and chronic liver damage.1 Interferon therapy apparently eradicates HCV in 20 to 30 percent of patients, but the follow-up in published studies is generally short (6 to 18 months) and never exceeds 3 to 5 years. Our findings indicate that at the doses used, interferon has little, if any, long-term efficacy in patients with chronic hepatitis C.
chronic hepatitis C; interferon
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11562/8699
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 23
social impact